Evaluation of Early Relapse After Mandibular Lengthening Surgery

October 15, 2018 updated by: Veerle Van Mossevelde, Universitair Ziekenhuis Brussel

Evaluation of Early Relapse After Mandibular Lengthening Surgery With or Without the Use of a Bone Graft Substitute at the Osteotomy Site.

The goal of this study is to evaluate whether the use of a bone graft substitute at the osteotomy site will result in better stability and diminish early relapse after mandibular lengthening surgery.

The study focuses on the evaluation of the following hypothesis:

The use of bone graft substitute at the osteotomy site has an influence on:

  • The 3-dimensional stability of the osteotomy site
  • Early relapse based in the plasticity of the site

Study Overview

Status

Unknown

Detailed Description

Bilateral sagittal split osteotomy (BSSO)of the mandible is a surgical procedure used to correct dentofacial discrepancies. Post-operative stability is of great concern for CMF (Cranio maxillo facial) surgeons as the goal is to achieve optimal functional outcomes, good aesthetic results and satisfaction of patients' concerns. Skeletal relapse is a known complication of mandibular lengthening surgery and is divided into two groups; short term or early relapse and long term or late relapse.

Short term relapse occurs within the first 6 to 8 weeks post-operatively and is due to intersegmental movement at the osteotomy site (osteotomy slippage) and osteosynthesis slippage. Late relapse is thought to be caused by progressive condylar resorption, a clinical entity affecting the temporomandibular joint.

The rationale to reconstruct the lateral cortical defect resulting from mandibular advancement with BSSO with a bone graft substitute lies in the prevention of an unaesthetic notching at the inferior border. The use of a self-hardening, space-occupying paste could add mechanical stability, thus increase 3D-stability at the osteotomy site and prevent early relapse.

The use of cone-beam computed tomography (CBCT) in the treatment planning and postoperative follow-up of orthognathic patients has provided the surgeons with a new three-dimensional imaging modality to evaluate the postoperative skeletal relapse and postoperative morphologic changes of the condyles. Skeletal relapse, as well as positional and dimensional changes of the condyles, can be quantified in three dimensions.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vlaams Brabant
      • Jette, Vlaams Brabant, Belgium, 1090
        • Recruiting
        • Universitair Ziekenhuis Brussel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 75 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Class II occlusion of non-syndromic origin, mandibular hypoplasia

Description

Inclusion Criteria:

  • Class II occlusion of non-syndromic origin, mandibular hypoplasia
  • Availability of pre- and postoperative CBCT scans of sufficient quality
  • Age: >10years

Exclusion Criteria:

  • Previous orthognathic surgical treatment
  • Simultaneously performed genioplasty
  • Plate osteosynthesis
  • Buccal plate fracture during surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
hydroset
patients receiving hydroset at osteotomy site
Bilateral sagittal split osteotomy of the mandible is a surgical procedure used to correct dentofacial discrepancies
Control
patients not receiving hydroset at osteotomy site
Bilateral sagittal split osteotomy of the mandible is a surgical procedure used to correct dentofacial discrepancies

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
early relapse by means of three dimensional color maps (CBCT)
Time Frame: the first 6 months postoperatively
evaluation at the osteotomy gap, the position of the condyles, rami and chin
the first 6 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
condylar resorption by means of three dimensional color maps (CBCT)
Time Frame: the first 6 months postoperatively
a three-dimensional volumetric analysis of the condylar head and the glenoid cavity
the first 6 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erica Coppey, MD, Universitair Ziekenhuis Brussel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 11, 2018

Primary Completion (ANTICIPATED)

September 1, 2019

Study Completion (ANTICIPATED)

December 30, 2019

Study Registration Dates

First Submitted

June 28, 2018

First Submitted That Met QC Criteria

October 15, 2018

First Posted (ACTUAL)

October 18, 2018

Study Record Updates

Last Update Posted (ACTUAL)

October 18, 2018

Last Update Submitted That Met QC Criteria

October 15, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Relapse

Clinical Trials on Bilateral sagittal split osteotomy

3
Subscribe